{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T04:36:33Z","timestamp":1794890193038,"version":"4.9.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","funder":[{"name":"Ensign Endowment for Gynecologic Cancer Research"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To describe population-level utilization of fertility-sparing surgery and outcome of reproductive-aged patients with early epithelial ovarian cancer who underwent fertility-sparing surgery in the United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      This retrospective study queried the National Cancer Institute's Surveillance, Epidemiology, and End Result Program. The study included 3,027 patients younger than age 50 years with stage I epithelial ovarian cancer receiving primary surgical therapy from 2007 to 2020.\n                      <jats:italic toggle=\"yes\">Fertility-sparing surgery<\/jats:italic>\n                      was defined as preservation of one ovary and the uterus for unilateral lesion and preservation of the uterus for bilateral lesions. Temporal trend of fertility-sparing surgery was assessed with linear segmented regression with log-transformation. Overall survival associated with fertility-sparing surgery was assessed with Cox proportional hazard regression model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      A total of 534 patients (17.6%) underwent fertility-sparing surgery. At the cohort level, the utilization of fertility-sparing surgery was 13.4% in 2007 and 21.8% in 2020 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      for trend=.009). Non-Hispanic White individuals (2.8-fold), those with high-grade serous histology (2.2-fold), and individuals with stage IC disease (2.3-fold) had a more than twofold increase in fertility-sparing surgery utilization during the study period (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      for trend&lt;.05). After controlling for the measured clinicopathologic characteristics, patients who received fertility-sparing surgery had overall survival comparable with that of patients who had nonsparing surgery (5-year rates 93.6% vs 92.1%, adjusted hazard ratio 0.87, 95% CI, 0.57\u20131.35). This survival association was consistent in high-grade serous (5-year rates 92.9% vs 92.4%), low-grade serous (100% vs 92.2%), clear cell (97.5% vs 86.1%), mucinous (92.1% vs 86.6%), low-grade endometrioid (95.7% vs 97.7%), and mixed (93.3% vs 83.7%) histology (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt;.05). In high-grade endometrioid tumor, fertility-sparing surgery was associated with decreased overall survival (5-year rates 71.9% vs 93.8%, adjusted hazard ratio 2.90, 95% CI, 1.09\u20137.67). Among bilateral ovarian lesions, fertility-sparing surgery was not associated with overall survival (5-year rates 95.8% vs 92.5%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.364). Among 41,914 patients who had epithelial ovarian cancer with any age and stage, those younger than age 50 years with stage I disease increased from 8.6% to 10.9% during the study period (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      for trend=.002).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Nearly one in five reproductive-aged patients with stage I epithelial ovarian cancer underwent fertility-sparing surgery in recent years in the United States. More than 90% of reproductive-aged patients with stage I epithelial ovarian cancer who underwent fertility-sparing surgery were alive at the 5-year timepoint, except for those with high-grade endometrioid tumors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000005530","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T17:00:36Z","timestamp":1716483636000},"page":"68-78","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer"],"prefix":"10.1097","volume":"144","author":[{"given":"Bonnie B.","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary S.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron D.","family":"Masjedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel S.","family":"Mandelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Klar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda D.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"key":"R3-20260826","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11764-016-0563-2","article-title":"Regret around fertility choices is decreased with pre-treatment counseling in gynecologic cancer patients","volume":"11","author":"Chan","year":"2017","journal-title":"J Cancer Surviv"},{"key":"R4-20260826","doi-asserted-by":"crossref","first-page":"ed62","DOI":"10.3332\/ecancer.2017.ed62","article-title":"Psychological impact of fertility preservation techniques in women with gynaecological cancer","volume":"11","author":"Lagan\u00e0","year":"2017","journal-title":"Ecancermedicalscience"},{"key":"R5-20260826","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1002\/cncr.29637","article-title":"Impact of fertility preservation counseling and treatment on psychological outcomes among women with cancer: a systematic review","volume":"121","author":"Deshpande","year":"2015","journal-title":"Cancer"},{"key":"R6-20260826","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R8-20260826","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1097\/IGC.0000000000000223","article-title":"Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumors","volume":"24","author":"Brown","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"R9-20260826","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1089\/jayao.2016.0086","article-title":"Fertility-sparing surgery should be the standard treatment in patients with malignant ovarian germ cell tumors","volume":"6","author":"Turkmen","year":"2017","journal-title":"J Adolesc Young Adult Oncol"},{"key":"R10-20260826","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ygyno.2019.05.029","article-title":"Conservative surgery in stage I adult type granulosa cells tumors of the ovary: results from the MITO-9 study","volume":"154","author":"Bergamini","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R11-20260826","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejogrb.2020.01.039","article-title":"Fertility preserving surgery for high-grade epithelial ovarian carcinoma confined to the ovary","volume":"248","author":"Nasioudis","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R12-20260826","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/AOG.0000000000002102","article-title":"All-cause mortality after fertility-sparing surgery for stage I epithelial ovarian cancer","volume":"130","author":"Melamed","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R13-20260826","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12885-020-06828-y","article-title":"Fertility sparing surgery vs radical surgery for epithelial ovarian cancer: a meta-analysis of overall survival and disease-free survival","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Cancer"},{"key":"R14-20260826","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/bjc.2016.254","article-title":"Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer","volume":"115","author":"Fruscio","year":"2016","journal-title":"Br J Cancer"},{"key":"R15-20260826","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1200\/JCO.2009.24.8617","article-title":"Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection","volume":"28","author":"Satoh","year":"2010","journal-title":"J Clin Oncol"},{"key":"R16-20260826","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.fertnstert.2015.06.008","article-title":"Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients","volume":"104","author":"Bentivegna","year":"2015","journal-title":"Fertil Steril"},{"key":"R17-20260826","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/cncr.32620","article-title":"Fertility-sparing surgery and survival among reproductive-age women with epithelial ovarian cancer in 2 cancer registries","volume":"126","author":"Crafton","year":"2020","journal-title":"Cancer"},{"key":"R18-20260826","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/jog.14302","article-title":"Fertility-sparing treatment for early-stage epithelial ovarian cancer: contemporary oncologic, reproductive and endocrinologic perspectives","volume":"46","author":"Mandelbaum","year":"2020","journal-title":"J Obstet Gynaecol Res"},{"key":"R19-20260826","first-page":"100071","article-title":"Fertility-sparing surgery for young women with ovarian endometrioid carcinoma: a multicenteric comparative study using inverse probability of treatment weighting","volume":"4","author":"Kajiyama","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol X"},{"key":"R22-20260826","first-page":"93","article-title":"The eighth edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"R24-20260826","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ygyno.2020.10.027","article-title":"Possible candidate population for neoadjuvant chemotherapy in women with advanced ovarian cancer","volume":"160","author":"Matsuo","year":"2021","journal-title":"Gynecol Oncol"},{"key":"R25-20260826","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2019.11.122","article-title":"Evolving population-based statistics for rare epithelial ovarian cancers","volume":"157","author":"Matsuo","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R26-20260826","doi-asserted-by":"crossref","first-page":"e2318602","DOI":"10.1001\/jamanetworkopen.2023.18602","article-title":"Uptake and outcomes of neoadjuvant chemotherapy among US patients with less common epithelial ovarian carcinomas","volume":"6","author":"Matsuo","year":"2023","journal-title":"JAMA Netw Open"},{"key":"R28-20260826","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1158\/1055-9965.EPI-17-0290","article-title":"Recent trends in ovarian cancer incidence and relative survival in the United States by race\/ethnicity and histologic subtypes","volume":"26","author":"Park","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R29-20260826","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"issue":"suppl 1","key":"R30-20260826","doi-asserted-by":"crossref","first-page":"e001290","DOI":"10.1136\/fmch-2021-001290","article-title":"Primer on binary logistic regression","volume":"9","author":"Harris","year":"2021","journal-title":"Fam Med Community Health"},{"key":"R31-20260826","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"R32-20260826","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/bmj.328.7447.1073","article-title":"The logrank test","volume":"328","author":"Bland","year":"2004","journal-title":"BMJ"},{"key":"R33-20260826","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Ser B (Methodological)"},{"key":"R35-20260826","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1002\/cncr.24461","article-title":"Fertility preservation in young women with epithelial ovarian cancer","volume":"115","author":"Wright","year":"2009","journal-title":"Cancer"},{"key":"R36-20260826","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/ijgc-2021-003115","article-title":"Fertility-sparing surgery for patients with stage IC2 or IC3 epithelial ovarian carcinoma: any evidence of safety?","volume":"32","author":"Nasioudis","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"R37-20260826","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/AOG.0000000000005044","article-title":"Disparities in fertility-sparing treatment and use of assisted reproductive technology after a diagnosis of cervical, ovarian, or endometrial cancer","volume":"141","author":"Jorgensen","year":"2023","journal-title":"Obstet Gynecol"},{"key":"R39-20260826","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1200\/JCO.2020.38.29_suppl.135","article-title":"Assessing the demographics of fertility preservation discussions in cancer patients [abstract]","volume":"38","author":"Auster","year":"2020","journal-title":"J Clin Oncol"},{"key":"R40-20260826","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0140-6736(00)03590-X","article-title":"Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma","volume":"357","author":"Vergote","year":"2001","journal-title":"Lancet"},{"key":"R41-20260826","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1136\/ijgc-2022-003560","article-title":"Oncologic and pregnancy outcomes after fertility-sparing surgery for stage I, low-grade endometrioid ovarian cancer","volume":"32","author":"Swift","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"R42-20260826","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ygyno.2016.02.023","article-title":"Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signatures","volume":"141","author":"Winterhoff","year":"2016","journal-title":"Gynecol Oncol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005530","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:01:42Z","timestamp":1787742102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005530","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,23]]},"assertion":[{"value":"2023-10-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}